Eli Lilly dives into hair loss treatments with investment in AI startup Absci

Allison covers what sizzling startups are getting as much as, and who’s financing them. She can also be co-host of the weekly biotech podcast, “The Readout Loud.” You may attain Allison on Sign at AllisonDeAngelis.01.

The pharmaceutical giants behind the monumentally profitable weight reduction medicine Wegovy and Mounjaro have been teasing an growth into different aesthetic fields like hair loss or skincare. 

Now, one among them is making a transfer, investing in a small startup growing a drugs to spur hair progress, and probably additionally deal with endometriosis. 

On Wednesday, Absci introduced that it raised $100 million from a gaggle led by Eli Lilly. Lilly introduced the lion’s share of the funding, handing over $40 million in change for fairness in Absci, which is publicly traded on the Nasdaq.